Back to Search Start Over

The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients

Authors :
Franco Citterio
Pierluca Piselli
Ghil Busnach
Claudia Cimaglia
Andrea Ambrosini
Luigi Biancone
Martina Taborelli
Diego Serraino
Maria Rosaria Campise
Giuseppe Tisone
Lucrezia Furian
Paola Todeschini
Nicola Bossini
Francesco Pisani
Maurizio Iaria
Massimiliano Veroux
Margherita Mangino
Flavia Caputo
Vincenzo Cantaluppi
Davide Argiolas
Marco Fiorentino
Taborelli M.
Serraino D.
Cimaglia C.
Furian L.
Biancone L.
Busnach G.
Todeschini P.
Bossini N.
Iaria M.
Campise M.R.
Veroux M.
Citterio F.
Ambrosini A.
Cantaluppi V.
Mangino M.
Pisani F.
Tisone G.
Fiorentino M.
Argiolas D.
Caputo F.
Piselli P.
Source :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 22(2)
Publication Year :
2021

Abstract

This study assessed the impact of cancer on the risk of death with a functioning graft of kidney transplant (KT) recipients, as compared to corresponding recipients without cancer. A matched cohort study was conducted using data from a cohort of 13245 individuals who had undergone KT in 17 Italian centers (1997–2017). Cases were defined as subjects diagnosed with any cancer after KT. For each case, two controls matched by gender, age, and year at KT were randomly selected from cohort members who were cancer-free at the time of diagnosis of the index case. Overall, 292 (20.5%) deaths with a functioning graft were recorded among 1425 cases and 238 (8.4%) among 2850 controls. KT recipients with cancer had a greater risk of death with a functioning graft (hazard ratio, HR=3.31) than their respective controls. This pattern was consistent over a broad range of cancer types, including non-Hodgkin lymphoma (HR=33.09), lung (HR=20.51), breast (HR=8.80), colon-rectum (HR=3.51), and kidney (HR=2.38). The survival gap was observed throughout the entire follow-up period, though the effect was more marked within 1year from cancer diagnosis. These results call for close posttransplant surveillance to detect cancers at earlier stages when treatments are more effective in improving survival.

Details

ISSN :
16006143
Volume :
22
Issue :
2
Database :
OpenAIRE
Journal :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES
Accession number :
edsair.doi.dedup.....dfeb2826e3a281ce636f1bc43b053428